<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hue SS</submitter><funding>National Medical Research Council</funding><pagination>453</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9856483</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(2)</volume><pubmed_abstract>Accurate diagnosis of the most common histological subtypes of small B-cell lymphomas is challenging due to overlapping morphological features and limitations of ancillary testing, which involves a large number of immunostains and molecular investigations. In addition, a common diagnostic challenge is to distinguish reactive lymphoid hyperplasia that do not require additional stains from such lymphomas that need ancillary investigations. We investigated if tissue-specific microRNA (miRNA) expression may provide potential biomarkers to improve the pathology diagnostic workflow. This study seeks to distinguish reactive lymphoid proliferation (RL) from small B-cell lymphomas, and to further distinguish the four main subtypes of small B-cell lymphomas. Two datasets were included: a discovery c</pubmed_abstract><journal>Cancers</journal><pubmed_title>Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas.</pubmed_title><pmcid>PMC9856483</pmcid><funding_grant_id>MOH-OFLCG18May-0004</funding_grant_id><pubmed_authors>Tang LWT</pubmed_authors><pubmed_authors>Ho YH</pubmed_authors><pubmed_authors>Hue SS</pubmed_authors><pubmed_authors>Tan SY</pubmed_authors><pubmed_authors>Bin Masroni MS</pubmed_authors><pubmed_authors>Ong DB</pubmed_authors><pubmed_authors>Jin Y</pubmed_authors><pubmed_authors>Cheng H</pubmed_authors><pubmed_authors>Leong SM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas.</name><description>Accurate diagnosis of the most common histological subtypes of small B-cell lymphomas is challenging due to overlapping morphological features and limitations of ancillary testing, which involves a large number of immunostains and molecular investigations. In addition, a common diagnostic challenge is to distinguish reactive lymphoid hyperplasia that do not require additional stains from such lymphomas that need ancillary investigations. We investigated if tissue-specific microRNA (miRNA) expression may provide potential biomarkers to improve the pathology diagnostic workflow. This study seeks to distinguish reactive lymphoid proliferation (RL) from small B-cell lymphomas, and to further distinguish the four main subtypes of small B-cell lymphomas. Two datasets were included: a discovery c</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-22T01:07:01.041Z</modification><creation>2025-04-05T19:52:22.083Z</creation></dates><accession>S-EPMC9856483</accession><cross_references><pubmed>36672402</pubmed><doi>10.3390/cancers15020453</doi></cross_references></HashMap>